Nanoviricides Inc (NNVC)
1.34
+0.06
(+4.69%)
USD |
NYAM |
Nov 22, 16:00
1.34
0.00 (0.00%)
After-Hours: 20:00
Nanoviricides Cash from Operations (Quarterly): -2.595M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -2.595M |
| June 30, 2024 | -1.481M |
| March 31, 2024 | -1.944M |
| December 31, 2023 | -1.719M |
| September 30, 2023 | -1.172M |
| June 30, 2023 | -1.499M |
| March 31, 2023 | -1.738M |
| December 31, 2022 | -1.400M |
| September 30, 2022 | -1.033M |
| June 30, 2022 | -1.398M |
| March 31, 2022 | -1.655M |
| December 31, 2021 | -2.114M |
| September 30, 2021 | -0.7242M |
| June 30, 2021 | -2.228M |
| March 31, 2021 | -1.435M |
| December 31, 2020 | -2.315M |
| September 30, 2020 | -2.236M |
| June 30, 2020 | -1.708M |
| March 31, 2020 | -2.397M |
| December 31, 2019 | -1.126M |
| September 30, 2019 | -1.434M |
| June 30, 2019 | -1.672M |
| March 31, 2019 | -2.010M |
| December 31, 2018 | -2.158M |
| September 30, 2018 | -0.9622M |
| Date | Value |
|---|---|
| June 30, 2018 | -3.519M |
| March 31, 2018 | -1.296M |
| December 31, 2017 | -1.404M |
| September 30, 2017 | -1.557M |
| June 30, 2017 | -1.009M |
| March 31, 2017 | -2.052M |
| December 31, 2016 | -2.611M |
| September 30, 2016 | -2.225M |
| June 30, 2016 | -1.382M |
| March 31, 2016 | -2.580M |
| December 31, 2015 | -1.213M |
| September 30, 2015 | -1.654M |
| June 30, 2015 | -1.256M |
| March 31, 2015 | -2.088M |
| December 31, 2014 | -1.172M |
| September 30, 2014 | -1.696M |
| June 30, 2014 | -0.9556M |
| March 31, 2014 | -1.861M |
| December 31, 2013 | -2.193M |
| September 30, 2013 | -1.324M |
| June 30, 2013 | -1.372M |
| March 31, 2013 | -1.708M |
| December 31, 2012 | -1.372M |
| September 30, 2012 | -1.345M |
| June 30, 2012 | -0.8965M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-2.595M
Minimum
Sep 2024
-0.7242M
Maximum
Sep 2021
-1.696M
Average
-1.682M
Median
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -2.061M |
| Palatin Technologies Inc | -7.016M |
| iBio Inc | -3.715M |
| Theriva Biologics Inc | -3.913M |
| Oragenics Inc | -1.970M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0468M |
| Cash from Financing (Quarterly) | 1.710M |
| Free Cash Flow | -7.934M |
| Free Cash Flow Per Share (Quarterly) | -0.1926 |
| Free Cash Flow Yield | -47.86% |